Sol-Gel Technologies Ltd. (SLGL)
83.98
+3.13
(+3.87%)
USD |
NASDAQ |
Feb 20, 16:00
83.00
-0.98
(-1.17%)
Pre-Market: 20:00
Sol-Gel Technologies EPS Diluted (Quarterly) : -2.133 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.223 |
| XTL Biopharmaceuticals Ltd. | -0.0292 |
| Can-Fite BioPharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.942M |
| Revenue (Quarterly) | 0.40M |
| Total Expenses (Quarterly) | 6.342M |
| Enterprise Value | 214.19M |
| Profit Margin (Quarterly) | -1.49K% |
| Earnings Yield | -3.84% |
| Normalized Earnings Yield | -3.841 |